Orthofix Medical Inc Total Assets
Orthofix Medical Inc total assets. Based on the latest financial reports, Orthofix Medical Inc (OFIX) holds total assets worth $886.60 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Orthofix Medical Inc stock valuation for the company's overall valuation and market capitalisation.
Total Assets of Orthofix Medical Inc (1992–2025)
Total assets of Orthofix Medical Inc from 1992 to 2025. This chart illustrates how Orthofix Medical Inc's total assets have evolved over time, based on quarterly financial data. See Orthofix Medical Inc share price for real-time trading data and today's change.
Orthofix Medical Inc - Asset Composition Analysis
Orthofix Medical Inc Total Assets Breakdown (December 2025)
Orthofix Medical Inc total assets breakdown as of December 2025. Orthofix Medical Inc's total assets of $886.60 Million consist of 49.0% current assets and 51.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.6% |
| Accounts Receivable | $135.75 Million | 16.0% |
| Inventory | $34.17 Million | 4.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $72.77 Million | 8.6% |
| Goodwill | $194.93 Million | 22.9% |
Asset Composition Trend (1992–2025)
This chart illustrates how Orthofix Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Orthofix Medical Inc short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Orthofix Medical Inc's current assets represent 49.0% of total assets in 2025, a decrease from 80.6% in 1992.
- Cash Position: Cash and equivalents constituted 9.6% of total assets in 2025, down from 41.6% in 1992.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 8.0% in 1992.
- Asset Diversification: The largest asset category is goodwill at 22.9% of total assets.
Orthofix Medical Inc Competitors by Total Assets
Key competitors of Orthofix Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Applied BioCode
TW:6598
|
Taiwan | NT$1.03 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$859.52 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$1.26 Million |
Orthofix Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.87 | 2.71 | 3.17 |
| Quick Ratio | 1.76 | 1.50 | 2.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $300.49 Million | $246.19 Million | $176.81 Million |
Orthofix Medical Inc - Advanced Valuation Insights
This section examines the relationship between Orthofix Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.92 |
| Latest Market Cap to Assets Ratio | 0.46 |
| Asset Growth Rate (YoY) | -4.8% |
| Total Assets | $850.65 Million |
| Market Capitalization | $392.90 Million USD |
Valuation Analysis
Below Book Valuation: The market values Orthofix Medical Inc's assets below their book value (0.46x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Orthofix Medical Inc's assets decreased by 4.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Orthofix Medical Inc (1992–2025)
The table below shows the annual total assets of Orthofix Medical Inc from 1992 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $850.65 Million | -4.77% |
| 2024-12-31 | $893.29 Million | -3.46% |
| 2023-12-31 | $925.32 Million | +101.76% |
| 2022-12-31 | $458.63 Million | -3.78% |
| 2021-12-31 | $476.62 Million | -9.36% |
| 2020-12-31 | $525.86 Million | +6.10% |
| 2019-12-31 | $495.62 Million | +6.21% |
| 2018-12-31 | $466.64 Million | +15.12% |
| 2017-12-31 | $405.35 Million | +8.94% |
| 2016-12-31 | $372.10 Million | -7.03% |
| 2015-12-31 | $400.22 Million | +1.79% |
| 2014-12-31 | $393.19 Million | -7.94% |
| 2013-12-31 | $427.10 Million | -15.30% |
| 2012-12-31 | $504.28 Million | -27.50% |
| 2011-12-31 | $695.55 Million | +15.16% |
| 2010-12-31 | $603.99 Million | +2.29% |
| 2009-12-31 | $590.47 Million | +5.21% |
| 2008-12-31 | $561.22 Million | -36.63% |
| 2007-12-31 | $885.66 Million | +2.71% |
| 2006-12-31 | $862.28 Million | +81.97% |
| 2005-12-31 | $473.86 Million | +9.92% |
| 2004-12-31 | $431.10 Million | +4.34% |
| 2003-12-31 | $413.18 Million | +87.15% |
| 2002-12-31 | $220.77 Million | +16.86% |
| 2001-12-31 | $188.91 Million | -0.80% |
| 2000-12-31 | $190.43 Million | +39.29% |
| 1999-12-31 | $136.72 Million | +11.70% |
| 1998-12-31 | $122.40 Million | +8.41% |
| 1997-12-31 | $112.90 Million | -0.18% |
| 1996-12-31 | $113.10 Million | +8.75% |
| 1995-12-31 | $104.00 Million | +83.42% |
| 1994-12-31 | $56.70 Million | +17.88% |
| 1993-12-31 | $48.10 Million | +31.78% |
| 1992-12-31 | $36.50 Million | -- |
About Orthofix Medical Inc
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhanc… Read more